| Co-pending U.S. Appl. No. 29/770,784, inventors Dobak; John et al., filed on Feb. 16, 2021. |
| Co-pending U.S. Appl. No. 29/770,785, inventors Dobak; John et al., filed on Feb. 16, 2021. |
| Co-pending U.S. Appl. No. 29/770,786, inventors Dobak; John et al., filed on Feb. 16, 2021. |
| Co-pending U.S. Appl. No. 29/796,477, inventor Dobak; John, filed on Jun. 24, 2021. |
| Co-pending U.S. Appl. No. 17/933,336, inventors Dubridge; Robert B. et al., filed Sep. 19, 2022. |
| Co-pending U.S. Appl. No. 29/866,396, inventor Makris; Gina, filed Sep. 9, 2022. |
| Co-pending U.S. Appl. No. 29/866,397, inventor Makris; Gina, filed Sep. 9, 2022. |
| Co-pending U.S. Appl. No. 29/866,398, inventor Makris; Gina, filed Sep. 9, 2022. |
| Co-pending U.S. Appl. No. 29/866,399, inventor Makris; Gina, filed Sep. 9, 2022. |
| U.S. Appl. No. 17/195,541 Office Action dated Sep. 28, 2022. |
| Cerda et al. Geometry and Physics of Wrinkling. Phys Rev Lett 90(7):074302 (2003). |
| Childs. Noninvasive gene expression testing in amelanotic melanoma. JAMA Dermatol 154(2):223-224(2018). |
| Co-pending U.S. Appl. No. 29/770,784, inventors Dobak; John et al., filed Feb. 16, 2021. |
| Co-pending U.S. Appl. No. 29/770,785, inventors Dobak; John et al., filed Feb. 16, 2021. |
| Co-pending U.S. Appl. No. 29/770,786, inventors Dobak; John et al., filed Feb. 16, 2021. |
| Co-pending U.S. Appl. No. 29/796,477, inventor Dobak; John, filed Jun. 24, 2021. |
| Dalbe et al. Multiscale Stick-Slip Dynamics of Adhesive Tape Peeling. Phys Rev Lett 115(12):128301 (2015). |
| De Zotti et al. Bending to Kinetic Energy Transfer in Adhesive Peel Front Microinstability. Phys Rev Lett 122(6):068005 (2019). |
| Ferris et al. Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month follow-up of negative test results and utility data from a large US registry study. Dermatology Online J 25(5):pii (May 2019). |
| Ferris et al. Noninvasive analysis of high-risk driver mutations and gene expression profiles in primary cutaneous melanoma. J Invest Dermatol 139:1127-1134 (2019). |
| Ferris et al. Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions. Melanoma Res 28(5):478-482 (2018). |
| Ferris et al. Utility of a noninvasive 2-gene molecular assay for cutaneous melanoma and effect on the decision to biopsy. JAMA Dermatol 153(7):675-680 (2017). |
| Gerami et al. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma. J Am Acad Dermatol 76(1):114-120.e2 (2017). |
| Hornberger et al. Clinical and economic implications of a noninvasive molecular pathology assay for early detection of melanoma. JAMA Dermatol 154(9):1-8 (2018). |
| Instructions for use DermTech adhesive skin biopsy kit. DermTech. Available at http://dermtech.com/wp-content/uploads/2015/10/dermtech-ifu-skin-collection-v7.pdf (Revised data Oct. 2015) (1 pg.). |
| Itoh et al. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS One 8(10):e77673 (2013). |
| Jansen et al. Gene expression analysis differentiates melanomas from Spitz nevi. J Drugs Dermatol 17(5):574-576 (2018). |
| Liu et al. Inhibition of p38 MAPK signaling augments skin tumorigenesis via NOX2 driven ROS generation. PLoS One 9(5):e97245 (2014). |
| Neagu et al. miRNAs in the Diagnosis and Prognosis of Skin Cancer. Front Cell Dev Biol 8:71 (2020). |
| PCT/US2016/30287 International Search Report and Written Opinion dated Aug. 16, 2016. |
| Rivers et al. Non-invasive gene expression testing to rule out melanoma. Skin Therapy Letter 23(5):1-4(2018). |
| Rivers et al. Ruling out Melanoma: A practical guide to improving performance through non-invasive gene expression testing. Skin Therapy Letter: Family Practice Edition 14(1):4-6 (2019). |
| Shen et al., Epigenetic and genetic dissections of UV-induced global gene dysregulation in skin cells through multi-omics analyses. Scientific Reports 7:42646 (2017). |
| Shen et al., Transcriptome analysis identifies the dysregulation of ultraviolet target genes in human skin cancers. PLoS One 11(9):e0163054 [1-14] (2016). |
| Siegel et al. Further consideration of the pigmented lesion assay-reply. JAMA Dermatol 155(3):393-394 (2019). |
| Thoroddsen et al. Stick-slip substructure in rapid tape peeling. Phys Rev Lett 82(4 Pt 2):046107 (2010). |
| Torres et al. MicroRNA Ratios Distinguish Melanomas from Nevi. J Invest Dermatol. 140(1):164-173.e7 (2020). |
| Wachsman et al. Differentiation of melanoma from dysplastic nevi in suspicious pigmented skin lesions by non-invasive tape stripping. Journal of Dermatology 127(Supp 1s):S145 (2007). |
| Yao et al. An adhesive patch-based skin biopsy device for molecular diagnostics and skin microbiome studies. J Drugs Dermatol 16:979-986 (2017). |
| Yao et al. Analytical Characteristics of a Noninvasive Gene Expression Assay for Pigmented Skin Lesions. Assay Drug Del Technol 14(6):355-363 (2016). |
Patent Grant
D989861
